Nanomagnetosols: magnetism opens up new perspectives for targeted aerosol delivery to the lung

Trends in Biotechnology

Volumn 26, Issue 2, 2008, Pages 59-63

  Plank, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOLS; BIOLOGICAL ORGANS; MAGNETIC FIELD EFFECTS; MAGNETISM; NANOPARTICLES;

AEROSOL DELIVERY; DRUG DOSES; NANOMAGNETIC DRUG TARGETING; NANOMAGNETOSOLS;

DRUG DELIVERY;

AEROSOL; DRUG DELIVERY SYSTEM; DRUG TARGETING; LUNG FUNCTION; MAGNETISM; NANOTECHNOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

AEROSOLS; DRUG DELIVERY SYSTEMS; FORECASTING; LUNG; MAGNETICS; NANOTECHNOLOGY;

EID: 38349149519     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2007.11.001     Document Type: Short Survey

References (18)

1. Gkiozos I., et al. Developments in the treatment of non-small cell lung cancer. Anticancer Res. 27 (2007) 2823-2827
2. Sharma S., et al. Development of inhalational agents for oncologic use. J. Clin. Oncol. 19 (2001) 1839-1847
3. Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc. Am. Thorac. Soc. 1 (2004) 315-320
4. Plank C., et al. Localized nucleic acid delivery: a discussion of selected methods. In: Schleef M. (Ed). DNA Pharmaceuticals (2005), Wiley-VCH Verlag GmbH & Co. KGaA 55-116
5. Dames P., et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat. Nano. 2 (2007) 495-499
6. Patton J.S., et al. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1 (2004) 338-344
7. Otterson G.A., et al. Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin. Cancer Res. 13 (2007) 1246-1252
8. Verschraegen C.F., et al. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin. Cancer Res. 10 (2004) 2319-2326
9. Widder K.J., et al. Magnetic microspheres: a model system of site specific drug delivery in vivo. Proc. Soc. Exp. Biol. Med. 158 (1978) 141-146
10. Ally J., et al. Factors affecting magnetic retention of particles in the upper airways: an in vitro and ex vivo study. J. Aerosol Med. 19 (2006) 491-509
11. Plank C., et al. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin. Biol. Ther. 3 (2003) 745-758
12. Lemke A.J., et al. MRI after magnetic drug targeting in patients with advanced solid malignant tumors. Eur. Radiol. 14 (2004) 1949-1955
13. Lubbe A.S., et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res. 56 (1996) 4694-4701
14. Lubbe A.S., et al. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 56 (1996) 4686-4693
15. Johnson J., et al. The MTC technology: a platform technology for the site-specific delivery of pharmaceutical agents. Eur. Cells and Mater. 3 (2002) 12-15
16. Alexiou C., et al. A high field gradient magnet for magnetic drug targeting. IEEE Trans. Appl. Supercond. 16 (2006) 1527-1530
17. Saito K., et al. Perfusion study of hypervascular hepatocellular carcinoma with SPIO. Magn. Reson. Med. Sci. 4 (2005) 151-158
18. Moller W., et al. Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects. J. Appl. Physiol. 97 (2004) 2200-2206